BUZZ-Boston Scientific rises after forecasting strong 2025 profit

Medical device maker Boston Scientific's BSX.N shares rise 3.4% to $107.02

Co forecast 2025 adj profit to be in the range of $2.80 per share to $2.87 per share, the midpoint of which is above analysts' est Of $2.81 - LSEG

Co forecasts 2025 revenue growth between 12.5% and 14.5% from last year

Co beat Q4 earnings estimates driven by steady demand for its heart devices, such as pacemakers and stents

Co reports Q4 adj profit of 70 cents per share, above analysts' est of 66 cents - LSEG

Co posts Q4 sales of $4.56 bln, above analysts' est of $4.43 bln - LSEG

BSX rose 54.5% in 2024